ACTIVE SUBSTANCE / INN

GANAXOLONE

Brand name(s): Ztalmy, ZTALMY
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA215904
Epileptic Syndromes;Spasms, Infantile
ACTIVE SUBSTANCE
Ganaxolone
REGULATORS
FDA · EMA
SPONSORS / MAH
Marinus Pharmaceuticals Emerald Limited, MARINUS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ZTALMYNDA215904MARINUSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ZtalmyMarinus Pharmaceuticals Emerald LimitedAuthorised26/07/2023Epileptic Syndromes;Spasms, Infantile

FULL INTELLIGENCE ON GANAXOLONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →